Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Carcinoma of bladder
|
309 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.100 | 1.000 | 10 | 2006 | 2016 | ||||
Malignant neoplasm of urinary bladder
|
316 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.100 | 1.000 | 10 | 2006 | 2016 | ||||
Bladder Neoplasm
|
281 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.090 | 1.000 | 9 | 2006 | 2016 | ||||
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C
|
82 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.090 | 0.889 | 9 | 2008 | 2019 | ||||
Breast Carcinoma
|
2793 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.050 | 1.000 | 5 | 2008 | 2019 | ||||
Malignant neoplasm of breast
|
3417 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.050 | 1.000 | 5 | 2008 | 2019 | ||||
Malignant Neoplasms
|
1641 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.050 | 1.000 | 5 | 2008 | 2019 | ||||
Primary malignant neoplasm
|
1374 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.050 | 1.000 | 5 | 2008 | 2019 | ||||
Nasopharyngeal carcinoma
|
320 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.020 | 1.000 | 2 | 2008 | 2017 | ||||
Squamous cell carcinoma of esophagus
|
329 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||
Azoospermia
|
70 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||
Oligospermia
|
72 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||
Colorectal Carcinoma
|
1962 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.050 | 0.800 | 5 | 2011 | 2015 | ||||
Gallbladder adenocarcinoma
|
2 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Gallbladder Carcinoma
|
75 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Malignant neoplasm of gallbladder
|
81 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Rectal Carcinoma
|
112 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.010 | 1 | 2011 | 2011 | |||||
Stage 0 Gallbladder Cancer AJCC v8
|
56 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Stage IIA Gallbladder Cancer AJCC v8
|
56 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Stage IIB Gallbladder Cancer AJCC v8
|
56 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Stage III Gallbladder Cancer AJCC v8
|
56 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Stage IV Gallbladder Cancer AJCC v8
|
56 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Carcinoma of lung
|
1204 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.040 | 0.500 | 4 | 2012 | 2014 | ||||
Malignant neoplasm of lung
|
1142 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.040 | 0.500 | 4 | 2012 | 2014 | ||||
Primary malignant neoplasm of lung
|
981 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.040 | 0.500 | 4 | 2012 | 2014 |